Retinoblastoma natural history, complications, and prognosis

Revision as of 20:42, 12 October 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma natural history, complications, and prognosis

CDC on Retinoblastoma natural history, complications, and prognosis

Retinoblastoma natural history, complications, and prognosis in the news

Blogs on Retinoblastoma natural history, complications, and prognosis

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma natural history, complications, and prognosis

Overview

If left untreated, the tumor fills the eye and completely destroys the globe in six months .Retinoblastoma is a rapidly growing tumor. Metastatic spread begins after six months and metastasized tumor is very rare at presentation. The tumor may spread through the subarachnoid space to the contralateral optic nerve or through the cerebrospinal fluid to the central nervous system or hematogenously to the lung, bone, or brain or by lymphatics if the tumor spreads anteriorly into the conjunctivae and eyelids, or extends into extraocular tissue. The most common routes of metastatic spread are direct infiltration via the optic nerve to the central nervous system, or spread via the choroid to the orbit. If untreated, death usually occurs in few years.

Natural History

[1]

Prognosis

The prognosis of retinoblastoma depends on the following:

  • Whether or not the tumor can be removed by surgery
  • The stage of the cancer: the size of the tumor, whether the cancer has spread
  • The child’s general health

Good prognosis depends upon early presentation of the child in health facility. Late presentation of the child in hospital is associated with poor prognosis.

Survival

Children with a germline RB1 mutation may continue to develop new tumors for a few years after diagnosis and treatment; for this reason, they need to be examined frequently. It is common practice for examinations to occur every 2 to 4 months for at least 28 months. The interval between exams is based on the stability of the disease and age of the child (i.e., less frequent visits as the child ages). A proportion of children who present with unilateral retinoblastoma will eventually develop disease in the opposite eye. Periodic examinations of the unaffected eye are performed until the germline status of the RB1 gene is determined.

Complications

The complications of retinoblastoma may be

  • Local spread of tumor
  • Development of other tumors
  • Cataract from radiotherapy
  • Failure of tooth eruption after radiotherapy
  • Bony deformities

References

  1. Singh, Arun D., Carol L. Shields, and Jerry A. Shields. "Prognostic factors in retinoblastoma." Journal of pediatric ophthalmology and strabismus 37.3 (2000): 134.

See also

Template:Nervous tissue tumors


Template:WikiDoc Sources